Thursday, July 9, 2026

pharma · Chemotherapy Induced Neuropathic Pain · DWTX

Dogwood Therapeutics

Dogwood Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Alpharetta, USA HQ
2020 Founded
9 Employees
Public company Type
DWTX · NYSE Ticker
Company details
Status
Public
HQ
Alpharetta, USA
Founded
2020
Employees
9
Programs
1
Drugs
2
Patents
7
Intelligence · Clinical Programs

Dogwood Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Dogwood Therapeutics.

Dogwood Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Halneuron

    Dogwood Therapeutics

    Chemotherapy Induced Neuropathic Pain

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Dogwood Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.